The Valley Desk

NCT06864143 · Interventional trial

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

Overall registry status Completed

Phase 2

Conditions Influenza, SARS-CoV-2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov